Bagsværd, Denmark, 24 March 2023 - Novo Nordisk today announced headline results from the PIONEER PLUS trial, a phase 3b, 68-week, efficacy and safety trial with once-daily oral semaglutide 25 mg
Bagsværd, Denmark, 23 March 2023 - Today, Novo Nordisk A/S held its Annual General Meeting. At the Annual General Meeting, Helge Lund, Chair of the Board of Directors communicated: "We are very pleased
Bagsværd, Denmark,?2 March 2023 - Novo Nordisk just announced plans to expand its research and development (R&D) presence in the greater Boston metro area, creating one of its largest R&D hubs outside
Novo Nordisk s sales increased by 26% in Danish kroner and by 16% at constant exchange rates to DKK 177 0 billion in 2022 privataaffarer.se - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from privataaffarer.se Daily Mail and Mail on Sunday newspapers.
Trading in Novo Nordisk shares by board members, executives and associated persons ugebrev.dk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ugebrev.dk Daily Mail and Mail on Sunday newspapers.